Blood Test to Detect and Classify Prostate Cancer Expected to Soon Enter Clinical Testing

Blood Test to Detect and Classify Prostate Cancer Expected to Soon Enter Clinical Testing
ANGLE announced that work by the Barts Cancer Institute on the Parsortix system, a blood test to both detect prostate cancer and evaluate its aggressiveness, has yielded positive results supporting its efficiency as a simple and non-invasive test with greater specificity than the current standard, the prostate-specific antigen (PSA) blood test. Parsortix is based on a technology able to detect

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *